1. Home
  2. SPPL vs ELUT Comparison

SPPL vs ELUT Comparison

Compare SPPL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPPL

SIMPPLE LTD.

N/A

Current Price

$2.00

Market Cap

37.0M

Sector

N/A

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

BUY

Current Price

$0.82

Market Cap

42.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SPPL
ELUT
Founded
2016
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.0M
42.5M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
SPPL
ELUT
Price
$2.00
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.1K
★ 48.4K
Earning Date
04-08-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 146.77
EPS
★ N/A
N/A
Revenue
N/A
★ $12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.50
$0.50
52 Week High
$7.00
$1.39

Technical Indicators

Market Signals
Indicator
SPPL
ELUT
Relative Strength Index (RSI) 44.89 48.25
Support Level $1.60 $0.78
Resistance Level $2.47 $1.07
Average True Range (ATR) 0.17 0.05
MACD 0.01 0.00
Stochastic Oscillator 21.35 55.67

Price Performance

Historical Comparison
SPPL
ELUT

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: